During a discussion with Siddharth Roy Kapur, Karan remarked that he might rename the company to "Pharma Productions" or "Kabhi Khushi Kabhie Serum"

Karan Johar recently sold a 50% stake in Dharma Productions to Adar Poonawalla, CEO of Serum Institute, with an investment of Rs 1000 crore. In his first interview post-deal, Karan humorously joked about renaming the company to two playful names,

Just as when everyone was wondering about the reason behind Adar Poonawalla's acquisition of Dharma Productions, Karan Johar seems to have just revealed it

It was recently announced that billionaire businessman Adar Poonawalla’s Serene Productions will invest ₹10 billion in Karan Johar’s Dharma Productions.

Johar explained that the primary reason behind the partnership was to take Dharma to the next level, where they could fund their own projects without outside support. He said that he wants to ‘chase’ the mid-budget films because that’s where the bigger profits lie.

The Rs 1,000 crore stake in Dharma is viewed as a high-multiple investment, but analysts suggest that if one film hits big, it could significantly boost Dharma’s trajectory.

Karan Johar, who made headlines after selling half of his stakes to Adar Poonawalla-led Serene Productions for Rs 1000 crore, breaks silence on the deal

In October, it was announced that Serene Productions, led by Adar Poonawalla, will acquire a 50% stake in filmmaker Karan Johar's Dharma Productions and Dharmatic Entertainment, for a total of ₹1,000 crore.

Karan Johar candidly admitted that he felt out of place in meetings with Adar Poonawalla, in the days and weeks leading up to their partnership on Dharma Productions.

After selling a 50 per cent stake in Dharma Productions to Serum Institute’s Adar Poonawalla, Karan Johar quipped that he is planning to rebrand his company. At the CNBC-TV18 Global Leadership Summit,